Silver Book Fact

Effectiveness of treating ischemic strokert-PA within 3 hours of symptom onset

A study of the  victims with effectiveness of treating ischemic strokert-PA within 3 hours of symptom onset showed a decrease in rehabilitation costs of $1.4 million and nursing home costs of $4.8 million, per 1,000 eligible rt-PA-treated patients.

Fagan, SC, LB Morgenstern, A Petitta, RE Ward, BC Tilley, JR Marler, SR Levine, JP Broderick, TG Kwiatkowski, M Frankel, TG Brott, and MD Walker; for the NINDS rt-PA Stroke Study Group. Cost- Effectiveness of Tissue Plasminogen Activator for Acute Ischemic Stroke. Neurology. 1998; 50(4): 883-890. http://www.neurology.org/content/50/4/883.abstract

Reference

Title
Cost- Effectiveness of Tissue Plasminogen Activator for Acute Ischemic Stroke
Publication
Neurology
Publication Date
1998
Authors
Fagan, SC, LB Morgenstern, A Petitta, RE Ward, BC Tilley, JR Marler, SR Levine, JP Broderick, TG Kwiatkowski, M Frankel, TG Brott, and MD Walker; for the NINDS rt-PA Stroke Study Group
Volume & Issue
Volume 50, Issue 4
Pages
883-890
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • AFib practice guidelines reduce direct health care costs
    The use of practice guidelines in atrial fibrillation (AF) patients significantly decreased hospitalization and resource utilization—with an average decrease in 30-day total direct health care costs of around $1,400 per patient.  
  • Cost-effectiveness of SAVR
    The cost-effectiveness ratio for surgical aortic valve replacement (SAVR), compared to no surgery, was estimated at $13,528 per quality-adjusted life year (QALY) (~$17,225 in 2017 dollars).  
  • Antihypertensive Medicines Have Prevented Deaths and Hospitalizations: Study quantified impact of high blood pressure drugs on the U.S. population 1999-2000  
  • Death rates from heart disease have decreased from 586.6 deaths per 100,000 persons in 1950, to 240.8 deaths per 100,000 persons in 2002.  
  • Effects of optimal anticoagulation among AFib patients
    If 50% of individuals with atrial fibrillation who do not receive prophylaxis were optimally anti-coagulated, 19,380 emboli would be prevented and $1.1 billion would be saved each year.